These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24614664)

  • 1. The potential role of scopolamine as antidepressant for mood disorder.
    Pae CU
    Clin Neuropharmacol; 2014; 37(2):67-8. PubMed ID: 24614664
    [No Abstract]   [Full Text] [Related]  

  • 2. Scopolamine as an antidepressant.
    Pae CU
    Clin Neuropharmacol; 2013; 36(3):102. PubMed ID: 23673916
    [No Abstract]   [Full Text] [Related]  

  • 3. Scopolamine as an antidepressant: a systematic review.
    Jaffe RJ; Novakovic V; Peselow ED
    Clin Neuropharmacol; 2013; 36(1):24-6. PubMed ID: 23334071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
    Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
    Yu H; Li M; Zhou D; Lv D; Liao Q; Lou Z; Shen M; Wang Z; Li M; Xiao X; Zhang Y; Wang C
    Neuropharmacology; 2018 Mar; 131():209-222. PubMed ID: 29274366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test.
    Pałucha-Poniewiera A; Podkowa K; Lenda T; Pilc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):155-161. PubMed ID: 28647535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response.
    Dong J; Zhou Q; Wei Z; Yan S; Sun F; Cai X
    J Affect Disord; 2018 Feb; 227():633-642. PubMed ID: 29174736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
    Podkowa K; Podkowa A; Sałat K; Lenda T; Pilc A; Pałucha-Poniewiera A
    Neuropharmacology; 2016 Dec; 111():169-179. PubMed ID: 27569995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early behavioural changes during antidepressant treatment in elderly patients.
    Kok RM; Vink D; Westers P; Nolen WA; Heeren TJ
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):769-71. PubMed ID: 18200609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interest of scopolamine as a treatment of major depressive disorder].
    Rigal A; Mouchabac S; Peretti CS
    Encephale; 2016 Dec; 42(6):568-573. PubMed ID: 27623122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraclinical monitoring of antidepressant prescription].
    Sechter D; Vandel S; Bonin B
    Encephale; 1995 Dec; 21 Spec No 4():39-41. PubMed ID: 8808345
    [No Abstract]   [Full Text] [Related]  

  • 12. Generalizability of antidepressant efficacy trials.
    Zimmerman M; Posternak MA; Chelminski I
    Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653
    [No Abstract]   [Full Text] [Related]  

  • 13. Amphetamine, but not methylphenidate, predicts antidepressant response.
    Gwirtsman HE; Guze BH
    J Clin Psychopharmacol; 1989 Dec; 9(6):453-4. PubMed ID: 2592595
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of the depressive component of bipolar disorder.
    Kalin NH
    Depress Anxiety; 1996-1997; 4(4):190-8. PubMed ID: 9166651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction: early onset of antidepressant action.
    Rosenbaum JF
    J Clin Psychiatry; 2001; 62 Suppl 4():3. PubMed ID: 11229786
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidepressant treatment for posttraumatic stress disorder (PTSD).
    Harris SE
    J Clin Psychiatry; 1986 May; 47(5):275. PubMed ID: 3700349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antidepressant therapy in internal diseases].
    Kapfhammer HP
    Internist (Berl); 1994 Sep; 35(9):832-41. PubMed ID: 7960565
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antidepressant therapy].
    Schmauss M
    MMW Fortschr Med; 2012 Apr; 154(7):69-72. PubMed ID: 22558879
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and effectiveness in the antidepressant treatment of depression: beyond metaanalysis.
    Kennedy SH; Bagby RM
    Can J Psychiatry; 1996 Dec; 41(10):609-10. PubMed ID: 8978937
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on: 'antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence'.
    Belmaker RH
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):577-8; author reply 579-82. PubMed ID: 18419849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.